Both in Pharmaceuticals
Ligand Pharmaceuticals vs Veradermics, Incorporated
Over the past year LGND returned +58.1% and MANE returned +253.9%; their daily moves had a correlation of 0.24.
LGND +58.1% MANE +253.9%Growth of $1, one year, split-adjusted
| Metric | LGND | MANE |
|---|---|---|
| Price | $313.52 | $133.61 |
| Market cap | $6.27B | $5.58B |
| Today | +2.12% | +3.15% |
| 1 month | +2.2% | +12.4% |
| 6 months | +35.0% | +16.4% |
| Year to date | +65.8% | — |
| 1 year | +63.9% | — |
| Revenue growth (YoY) | −31.8% | — |
| Gross margin | 83.7% | — |
| Net margin | −36.2% | — |
| P/E (TTM) | 121.9× | — |
| Price / sales | 24.7× | — |
| Net cash | -$653.3M | $819.9M |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 63.8% |
| Short % of float | 13.3% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).